170 related articles for article (PubMed ID: 29475064)
1. Ursodeoxycholyl lysophosphatidylethanolamide negatively regulates TLR-mediated lipopolysaccharide response in human THP-1-derived macrophages.
Horvatova A; Utaipan T; Otto AC; Zhang Y; Gan-Schreier H; Pavek P; Pathil A; Stremmel W; Chamulitrat W
Eur J Pharmacol; 2018 Apr; 825():63-74. PubMed ID: 29475064
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory properties of ursodeoxycholyl lysophosphatidylethanolamide in endotoxin-mediated inflammatory liver injury.
Ludwig JM; Zhang Y; Chamulitrat W; Stremmel W; Pathil A
PLoS One; 2018; 13(5):e0197836. PubMed ID: 29795632
[TBL] [Abstract][Full Text] [Related]
3. The synthetic bile acid-phospholipid conjugate ursodeoxycholyl lysophosphatidylethanolamide suppresses TNFα-induced liver injury.
Pathil A; Warth A; Chamulitrat W; Stremmel W
J Hepatol; 2011 Apr; 54(4):674-84. PubMed ID: 21146893
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory effects of ursodeoxycholic acid by lipopolysaccharide-stimulated inflammatory responses in RAW 264.7 macrophages.
Ko WK; Lee SH; Kim SJ; Jo MJ; Kumar H; Han IB; Sohn S
PLoS One; 2017; 12(6):e0180673. PubMed ID: 28665991
[TBL] [Abstract][Full Text] [Related]
5. Bile salt-phospholipid conjugate ursodeoxycholyl lysophosphatidylethanolamide as a hepatoprotective agent.
Chamulitrat W; Burhenne J; Rehlen T; Pathil A; Stremmel W
Hepatology; 2009 Jul; 50(1):143-54. PubMed ID: 19496180
[TBL] [Abstract][Full Text] [Related]
6. Ursodeoxycholyl Lysophosphatidylethanolamide modifies aberrant lipid profiles in NAFLD.
Pathil A; Liebisch G; Okun JG; Chamulitrat W; Schmitz G; Stremmel W
Eur J Clin Invest; 2015 Sep; 45(9):925-31. PubMed ID: 26108973
[TBL] [Abstract][Full Text] [Related]
7. Ursodeoxycholyl lysophosphatidylethanolamide protects against hepatic ischemia and reperfusion injury in mice.
Wang J; Deng X; Yi S; Pathil A; Zhang W; Setchell K; Stremmel W; Chamulitrat W
Shock; 2015 Apr; 43(4):379-86. PubMed ID: 25526375
[TBL] [Abstract][Full Text] [Related]
8. The Anti-Inflammatory Effect of Algae-Derived Lipid Extracts on Lipopolysaccharide (LPS)-Stimulated Human THP-1 Macrophages.
Robertson RC; Guihéneuf F; Bahar B; Schmid M; Stengel DB; Fitzgerald GF; Ross RP; Stanton C
Mar Drugs; 2015 Aug; 13(8):5402-24. PubMed ID: 26308008
[TBL] [Abstract][Full Text] [Related]
9. Ursodeoxycholyl lysophosphatidylethanolamide attenuates hepatofibrogenesis by impairment of TGF-β1/Smad2/3 signalling.
Pathil A; Mueller J; Ludwig JM; Wang J; Warth A; Chamulitrat W; Stremmel W
Br J Pharmacol; 2014 Nov; 171(22):5113-26. PubMed ID: 25041068
[TBL] [Abstract][Full Text] [Related]
10. Ursodeoxycholyl Lysophosphatidylethanolamide Protects Against CD95/FAS-Induced Fulminant Hepatitis.
Utaipan T; Otto AC; Gan-Schreier H; Chunglok W; Pathil A; Stremmel W; Chamulitrat W
Shock; 2017 Aug; 48(2):251-259. PubMed ID: 28060213
[TBL] [Abstract][Full Text] [Related]
11. Aloe vera downregulates LPS-induced inflammatory cytokine production and expression of NLRP3 inflammasome in human macrophages.
Budai MM; Varga A; Milesz S; Tőzsér J; Benkő S
Mol Immunol; 2013 Dec; 56(4):471-9. PubMed ID: 23911403
[TBL] [Abstract][Full Text] [Related]
12. Comparison of different bile acid-phospholipid conjugates in acute hepatitis.
Pathil A; Warth A; Chamulitrat W; Stremmel W
Eur J Clin Invest; 2012 Feb; 42(2):130-8. PubMed ID: 21707612
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of chroman carboxamide on interleukin-6 expression in response to lipopolysaccharide by preventing nuclear factor-kappaB activation in macrophages.
Kim BH; Lee KH; Chung EY; Chang YS; Lee H; Lee CK; Min KR; Kim Y
Eur J Pharmacol; 2006 Aug; 543(1-3):158-65. PubMed ID: 16797005
[TBL] [Abstract][Full Text] [Related]
14. Nodakenin suppresses lipopolysaccharide-induced inflammatory responses in macrophage cells by inhibiting tumor necrosis factor receptor-associated factor 6 and nuclear factor-κB pathways and protects mice from lethal endotoxin shock.
Rim HK; Cho W; Sung SH; Lee KT
J Pharmacol Exp Ther; 2012 Sep; 342(3):654-64. PubMed ID: 22637723
[TBL] [Abstract][Full Text] [Related]
15. Alpinetin inhibits LPS-induced inflammatory mediator response by activating PPAR-γ in THP-1-derived macrophages.
Hu K; Yang Y; Tu Q; Luo Y; Ma R
Eur J Pharmacol; 2013 Dec; 721(1-3):96-102. PubMed ID: 24104193
[TBL] [Abstract][Full Text] [Related]
16. Bivalent Ligand UDCA-LPE Inhibits Pro-Fibrogenic Integrin Signalling by Inducing Lipid Raft-Mediated Internalization.
Su J; Gan-Schreier H; Goeppert B; Chamulitrat W; Stremmel W; Pathil A
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347788
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory effects of Phyllanthus amarus Schum. & Thonn. through inhibition of NF-κB, MAPK, and PI3K-Akt signaling pathways in LPS-induced human macrophages.
Harikrishnan H; Jantan I; Haque MA; Kumolosasi E
BMC Complement Altern Med; 2018 Jul; 18(1):224. PubMed ID: 30045725
[TBL] [Abstract][Full Text] [Related]
18. DXXK exerts anti-inflammatory effects by inhibiting the lipopolysaccharide-induced NF-κB/COX-2 signalling pathway and the expression of inflammatory mediators.
Yu Y; Li X; Qu L; Chen Y; Dai Y; Wang M; Zou W
J Ethnopharmacol; 2016 Feb; 178():199-208. PubMed ID: 26571085
[TBL] [Abstract][Full Text] [Related]
19. Cnidilide, an alkylphthalide isolated from the roots of Cnidium officinale, suppresses LPS-induced NO, PGE
Lee WS; Shin JS; Jang DS; Lee KT
Int Immunopharmacol; 2016 Nov; 40():146-155. PubMed ID: 27591413
[TBL] [Abstract][Full Text] [Related]
20. Ursodeoxycholyl lysophosphatidylethanolamide protects against hepatic ischemia/reperfusion injury via phospholipid metabolism-mediated mitochondrial quality control.
Gu J; Zhang T; Guo J; Chen K; Wang G; Li H; Wang J
FASEB J; 2020 May; 34(5):6198-6214. PubMed ID: 32162746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
